SCHEMBL21135362

SCHEMBL21135362

Cc1c(N)c(C)c(S(=O)(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c(C)c1N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G1B P04054 1/20 0.51
ATG4B Q9Y4P1 1/20 0.51
MAPK1 P28482 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
MAPT P10636 1/20 0.48
CYP2C19 P33261 1/20 0.48
P2RX1 P51575 1/20 0.47
POLB P06746 1/20 0.44
FFAR4 Q5NUL3 3/20 0.43
FFAR1 O14842 2/20 0.43
CDK1 P06493 2/20 0.43
CCNB1 P14635 2/20 0.43
CCNA2 P20248 2/20 0.43
CDK2 P24941 2/20 0.43
CDK7 P50613 2/20 0.43
CCNH P51946 2/20 0.43
CCNA1 P78396 2/20 0.43
PPARG P37231 1/20 0.42
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15761595 0.87 MAPK1 (0.52) PLA2G1BATG4BMAPK1CYP1A2CYP3A4
SCHEMBL20421281 0.84 LMNA (0.54) PLA2G1BATG4BMAPK1CYP1A2CYP3A4
SCHEMBL30229904 0.82 CYP1A2 (0.58) PLA2G1BATG4BMAPK1CYP1A2CYP3A4
SCHEMBL15756000 0.81 CYP1A2 (0.61) PLA2G1BATG4BMAPK1CYP1A2CYP3A4
SCHEMBL15761594 0.78 MAPT (0.74) PLA2G1BATG4BMAPK1CYP1A2CYP3A4
SCHEMBL15761586 0.75 CYP1A2 (0.64) PLA2G1BATG4BMAPK1CYP1A2CYP3A4
SCHEMBL30230067 0.74 MAPK1 (0.56) PLA2G1BATG4BMAPK1CYP1A2CYP3A4
SCHEMBL30229886 0.73 CYP1A2 (0.55) PLA2G1BATG4BMAPK1CYP1A2CYP3A4
SCHEMBL15761593 0.73 PPARG (0.58) PLA2G1BATG4BMAPK1CYP3A4P2RX1
SCHEMBL24177153 0.72 CYP3A4 (0.45) PLA2G1BATG4BMAPK1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10717706-B2 M-phenylenediamine compound and method for producing polymer compound using same FUJIFILM CORPORATION (JP) 2020-07-21 US disclosed
US-20190177270-A1 NOVEL M-PHENYLENEDIAMINE COMPOUND AND METHOD FOR PRODUCING POLYMER COMPOUND USING SAME FUJIFILM CORPORATION (JP) 2019-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190177270-A1 NOVEL M-PHENYLENEDIAMINE COMPOUND AND METHOD FOR PRODUCING POLYMER COMPOUND USING SAME PNMT, PRMT9, HRH3 PLA2G1B 3522/4885ATG4B 4234/4885MAPK1 1146/4885
US-10717706-B2 M-phenylenediamine compound and method for producing polymer compound using same PNMT, HRH3, PRMT9 PLA2G1B 3780/4885ATG4B 4183/4885MAPK1 1262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.